5DZ-31490-84462
5 vaccinations
6 coded responses
46 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 930 / CA
- Registered
- 2021-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-23
Registered in v-safe
-
2021-02-23
Dose 1 — Moderna
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
-
2021-03-09
Survey response — day 14, dose 1MedDRA: Dizziness, Fatigue, Injection site erythema, Injection site pruritus — Feeling: GoodFree text: Redness with mild itching at injection site began on 8th day after first dose and lasted about 4 days; periodic fatigue and mild lightheadnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
-
2021-03-23
Dose 2 — Moderna
-
2021-03-23
Survey response — day 0, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Some mild arm soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Vision blurred, Vitreous floaters — Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteFree text: Momentary blurred vision when facing direct sunlight and threadlike lines appearing in the corner of one eye; not painfulMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-06-22
- 2021-09-21
-
2021-11-18
Dose 3 — Pfizer-BioNTech
- 2022-03-23
- 2022-05-19
-
2022-05-25
Dose 4 — Pfizer-BioNTech
- 2022-05-25
- 2022-05-26
- 2022-05-27
- 2022-05-28
-
2022-05-29
Survey response — days 1–6 daily, dose 4MedDRA: Axillary pain — Feeling: GoodFree text: Mild ache under arm where I got injectionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-30
- 2022-05-31
- 2022-06-01
- 2022-06-08
- 2022-06-15
-
2022-06-22
Survey response — day 28, dose 4MedDRA: Ear congestion, Fatigue, Rhinorrhoea, Sneezing — Feeling: FairFree text: Fatigue, runny nose, ear congestion, sneezingMedDRA releases: 2024-11 · check-in free text available
-
2022-06-29
Survey response — day 35, dose 4MedDRA: Cough, Ear congestion, Fatigue, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to do your normal daily activitiesFree text: Runny nose, cough, sneezing, congested ears, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-07-06
- 2022-08-24
-
2022-10-14
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-23
- 2022-11-23
- 2022-11-25
- 2023-01-13
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Moderna | |
| 2 | 2021-03-23 | Moderna | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
| 4 | 2022-05-25 | Pfizer-BioNTech | No |
| 5 | 2022-10-14 | Pfizer-BioNTech | Flu |
Free text
Release 5 — day 14, dose 1
Symptoms: Redness with mild itching at injection site began on 8th day after first dose and lasted about 4 days; periodic fatigue and mild lightheadness
Release 6 — day 0, dose 2
Systemic reaction (other): Some mild arm soreness at injection site
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Momentary blurred vision when facing direct sunlight and threadlike lines appearing in the corner of one eye; not painful
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Mild ache under arm where I got injection
Release 12 — day 28, dose 4
Symptoms: Fatigue, runny nose, ear congestion, sneezing
Release 12 — day 35, dose 4
Symptoms: Runny nose, cough, sneezing, congested ears, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Ear congestion | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Vitreous floaters | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release